#ADA25: Vertex's diabetes cell therapy allows 10 patients to come off insulin
Vertex Pharmaceuticals’ cell therapy for type 1 diabetes allowed 10 of 12 patients (83%) to stop taking insulin a year after they were infused, according to results presented Friday. The data came from the Phase ...
Vertex Pharmaceuticals’ cell therapy for type 1 diabetes allowed 10 of 12 patients (83%) to stop taking insulin a year after they were infused, according to results presented Friday.
The data came from the Phase ...
